 - Have received prior treatment with any anti-angiogenic compound or any investigational treatment e.g. Macugen, Avastin bevacizumab, Ruboxistaurin, Lucentis ranibizumab, Retaane anecortave acetate, squalamine, siRNA, VEGF-Trap etc. for neovascular AMD 